BrdU antibodies

The thymidine analogue bromodeoxyuridine (BrdU) has a long, colorful history of heavy use in molecular and cytokinetic studies (1, 2). BrDU is incorporated into newly synthesized DNA only in S-phase cells, and then immunocytochemically detected with BrDU antibodies. This method allows for extremely accurate and comprehensive comparative studies of a variety of cells ranging from normal to neoplastic.

BrdU (5-bromo-2-deoxyuridine) is a thymidine analogue which is incorporated into the cells of DNA synthetic phase. Replicating cells undergo DNA synthesis in a highly regulated, S-phase of the cell cycle. The regulation of cell proliferation is central to tissue morphogenesis during the development of multicellular organisms. Furthermore, loss of control of cell proliferation underlies the pathology of diseases like cancer.